Journal
NATURE COMMUNICATIONS
Volume 8, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-017-00493-9
Keywords
-
Categories
Funding
- Ministry of Science and Technology [MOST102-2628-B-182A-012-MY3, MOST103-2632-B-182-001, MOST104-2632-B-182-001, MOST105-2632-B-182-001, MOST104-2321-B-182-007-MY3, MOST104-2320-B-182-033]
- Ministry of Education [EMRPD1G0031, 0141]
- Chang Gung Memorial Hospital, Taiwan [CMRPG3F0152, CMRPG3C1913, CIRPG3B0012, CIRPG3B0013, CIRPD3B0012, CMRPD1D0101, CMRPD1D0102, CMRPD1D0103, CMRPD3E0071, CMRPD3E0072, CMRPG3D1511, CMRPG3D1512, CMRPG3D1513]
- National Research Program for Biopharmaceuticals [MOST 104-2325-B-492-001]
Ask authors/readers for more resources
Oral squamous cell carcinoma is a prominent cancer worldwide, particularly in Taiwan. By integrating omics analyses in 50 matched samples, we uncover in Taiwanese patients a predominant mutation signature associated with cytidine deaminase APOBEC, which correlates with the upregulation of APOBEC3A expression in the APOBEC3 gene cluster at 22q13. APOBEC3A expression is significantly higher in tumors carrying APOBEC3B-deletion allele(s). High-level APOBEC3A expression is associated with better overall survival, especially among patients carrying APOBEC3B-deletion alleles, as examined in a second cohort (n = 188; p = 0.004). The frequency of APOBEC3B-deletion alleles is similar to 50% in 143 genotyped oral squamous cell carcinoma - Taiwan samples (27A3B(-/-): 89A3B(+/-): 27A3B(+/+)), compared to the 5.8% found in 314 OSCC-TCGA samples. We thus report a frequent APOBEC mutational profile, which relates to a APOBEC3B-deletion germline polymorphism in Taiwanese oral squamous cell carcinoma that impacts expression of APOBEC3A, and is shown to be of clinical prognostic relevance. Our finding might be recapitulated by genomic studies in other cancer types.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available